Alessandro Maria Maria Vannucchi (Alessandro M Vannucchi, Alessandro Maria Vannucchi, Alessandro Maria Vannucchi, Alessandro Vannucchi)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 113

Top Venues

American journal of hematology

Blood cancer journal

Leukemia

Blood

University of Florence

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Florence Nov 01 2001

Italy

Associate professor :: Clinical and Experimental medicine

Publications

Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances 8 (17) (2024)
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, Francesco Mannelli, Giuseppe Gaetano Loscocco, Leonardo Signori, Chiara Pessina, Ilaria Colugnat, Raffaela Aquila, Manjola Balliu, Chiara Maccari, Simone Romagnoli, Chiara Paoli, Elena Nacca, Lorenzo Fagiolo, Margherita Maffioli, Tiziano Barbui, Francesco Passamonti, Alessandro Maria Maria Vannucchi
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American journal of hematology 99 (8) (2024)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management. American journal of hematology 99 (4) (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Chiara Carretta, Sandra Parenti, Matteo Bertesi, Sebastiano Rontauroli, Filippo Badii, Lara Tavernari, Elena Genovese, Marica Malerba, Elisa Papa, Samantha Sperduti, Elena Enzo, Margherita Mirabile, Francesca Pedrazzi, Anita Neroni, Camilla Tombari, Barbara Mora, Margherita Maffioli, Marco Mondini, Marco Brociner, Monica Maccaferri, Elena Tenedini, Silvia Martinelli, Niccolò Bartalucci, Elisa Bianchi, Livio Casarini, Leonardo Potenza, Mario Luppi, Enrico Tagliafico, Paola Guglielmelli, Manuela Simoni, Francesco Passamonti, Ruggiero Norfo, Alessandro Maria Maria Vannucchi, Rossella Manfredini, null null
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms. Leukemia (2024)
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances 8 (17) (2024)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Risk models in myelofibrosis-the past, present, and future. American journal of hematology 99 (4) (2024)
Paola Guglielmelli, Natasha Szuber, Naseema Gangat, Giulio Capecchi, Chiara Maccari, Michaël Harnois, Omer Karrar, Maymona Abdelmagid, Manjola Balliu, Elena Nacca, Alessandro Atanasio, Ilaria Sestini, Audrey Désilets, Giuseppe Gaetano Loscocco, Giada Rotunno, Lambert Busque, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
CALR mutation burden in essential thrombocythemia and disease outcome. Blood (2024)
Lara Tavernari, Sebastiano Rontauroli, Ruggiero Norfo, Margherita Mirabile, Monica Maccaferri, Barbara Mora, Elena Genovese, Sandra Parenti, Chiara Carretta, Elisa Bianchi, Matteo Bertesi, Francesca Pedrazzi, Elena Tenedini, Silvia Martinelli, Maria Teresa Bochicchio, Paola Guglielmelli, Leonardo Potenza, Alessandro Lucchesi, Francesco Passamonti, Enrico Tagliafico, Mario Luppi, Alessandro Maria Maria Vannucchi, Rossella Manfredini, null null
Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts. American journal of hematology (2024)
Aaron T Gerds, Claire N Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, Francesco Mannelli, Giuseppe Gaetano Loscocco, Leonardo Signori, Chiara Pessina, Ilaria Colugnat, Raffaela Aquila, Manjola Balliu, Chiara Maccari, Simone Romagnoli, Chiara Paoli, Elena Nacca, Lorenzo Fagiolo, Margherita Maffioli, Tiziano Barbui, Francesco Passamonti, Alessandro Maria Maria Vannucchi
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American journal of hematology (2024)
Bianca Rocca, Alberto Tosetto, Giovanna Petrucci, Elena Rossi, Silvia Betti, Denise Soldati, Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, Alfredo Dragani, Mauro Di Ianni, Paola Ranalli, Francesca Palandri, Nicola Vianelli, Eloise Beggiato, Giuseppe Lanzarone, Marco Ruggeri, Giuseppe Carli, Elena Maria Elli, Rossella Renso, Maria Luigia Randi, Irene Bertozzi, Giuseppe Gaetano Loscocco, Alessandra Ricco, Giorgina Specchia, Alessandro Maria Maria Vannucchi, Francesco Rodeghiero, Valerio De Stefano, Carlo Patrono, null null
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial. American journal of hematology 99 (8) (2024)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Risk models in myelofibrosis-the past, present, and future. American journal of hematology 99 (4) (2024)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management. American journal of hematology 99 (4) (2024)
Bianca Rocca, Alberto Tosetto, Giovanna Petrucci, Elena Rossi, Silvia Betti, Denise Soldati, Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, Alfredo Dragani, Mauro Di Ianni, Paola Ranalli, Francesca Palandri, Nicola Vianelli, Eloise Beggiato, Giuseppe Lanzarone, Marco Ruggeri, Giuseppe Carli, Elena Maria Elli, Rossella Renso, Maria Luigia Randi, Irene Bertozzi, Giuseppe Gaetano Loscocco, Alessandra Ricco, Giorgina Specchia, Alessandro Maria Maria Vannucchi, Francesco Rodeghiero, Valerio De Stefano, Carlo Patrono, null null
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial. American journal of hematology 99 (8) (2024)
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, Francesco Mannelli, Giuseppe Gaetano Loscocco, Leonardo Signori, Chiara Pessina, Ilaria Colugnat, Raffaela Aquila, Manjola Balliu, Chiara Maccari, Simone Romagnoli, Chiara Paoli, Elena Nacca, Lorenzo Fagiolo, Margherita Maffioli, Tiziano Barbui, Francesco Passamonti, Alessandro Maria Maria Vannucchi
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American journal of hematology 99 (8) (2024)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management. American journal of hematology 99 (4) (2024)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management. American journal of hematology (2024)
Paola Guglielmelli, Natasha Szuber, Naseema Gangat, Giulio Capecchi, Chiara Maccari, Michaël Harnois, Omer Karrar, Maymona Abdelmagid, Manjola Balliu, Elena Nacca, Alessandro Atanasio, Ilaria Sestini, Audrey Désilets, Giuseppe Gaetano Loscocco, Giada Rotunno, Lambert Busque, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
CALR mutation burden in essential thrombocythemia and disease outcome. Blood (2024)
Daniele Capitanio, Francesca R Calledda, Vittorio Abbonante, Daniele Cattaneo, Manuela Moriggi, Bartalucci Niccolò, Cristina Bucelli, Delfina Tosi, Umberto Gianelli, Alessandro Maria Maria Vannucchi, Alessandra Iurlo, Cecilia Gelfi, Alessandra Balduini, Alessandro Malara
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis. Leukemia (2024)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Risk models in myelofibrosis-the past, present, and future. American journal of hematology (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Bianca Rocca, Alberto Tosetto, Giovanna Petrucci, Elena Rossi, Silvia Betti, Denise Soldati, Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, Alfredo Dragani, Mauro Di Ianni, Paola Ranalli, Francesca Palandri, Nicola Vianelli, Eloise Beggiato, Giuseppe Lanzarone, Marco Ruggeri, Giuseppe Carli, Elena Maria Elli, Rossella Renso, Maria Luigia Randi, Irene Bertozzi, Giuseppe Gaetano Loscocco, Alessandra Ricco, Giorgina Specchia, Alessandro Maria Maria Vannucchi, Francesco Rodeghiero, Valerio De Stefano, Carlo Patrono, null null
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial. American journal of hematology 99 (8) (2024)
Bianca Rocca, Alberto Tosetto, Giovanna Petrucci, Elena Rossi, Silvia Betti, Denise Soldati, Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, Alfredo Dragani, Mauro Di Ianni, Paola Ranalli, Francesca Palandri, Nicola Vianelli, Eloise Beggiato, Giuseppe Lanzarone, Marco Ruggeri, Giuseppe Carli, Elena Maria Elli, Rossella Renso, Maria Luigia Randi, Irene Bertozzi, Giuseppe Gaetano Loscocco, Alessandra Ricco, Giorgina Specchia, Alessandro Maria Maria Vannucchi, Francesco Rodeghiero, Valerio De Stefano, Carlo Patrono, null null
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial. American journal of hematology (2024)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Risk models in myelofibrosis-the past, present, and future. American journal of hematology 99 (4) (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Daniele Capitanio, Francesca R Calledda, Vittorio Abbonante, Daniele Cattaneo, Manuela Moriggi, Bartalucci Niccolò, Cristina Bucelli, Delfina Tosi, Umberto Gianelli, Alessandro Maria Maria Vannucchi, Alessandra Iurlo, Cecilia Gelfi, Alessandra Balduini, Alessandro Malara
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis. Leukemia 38 (9) (2024)
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, Francesco Mannelli, Giuseppe Gaetano Loscocco, Leonardo Signori, Chiara Pessina, Ilaria Colugnat, Raffaela Aquila, Manjola Balliu, Chiara Maccari, Simone Romagnoli, Chiara Paoli, Elena Nacca, Lorenzo Fagiolo, Margherita Maffioli, Tiziano Barbui, Francesco Passamonti, Alessandro Maria Maria Vannucchi
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American journal of hematology 99 (8) (2024)
Paola Guglielmelli, Natasha Szuber, Naseema Gangat, Giulio Capecchi, Chiara Maccari, Michaël Harnois, Omer Karrar, Maymona Abdelmagid, Manjola Balliu, Elena Nacca, Alessandro Atanasio, Ilaria Sestini, Audrey Désilets, Giuseppe Gaetano Loscocco, Giada Rotunno, Lambert Busque, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
CALR mutation burden in essential thrombocythemia and disease outcome. Blood 143 (13) (2024)
Daniele Capitanio, Francesca R Calledda, Vittorio Abbonante, Daniele Cattaneo, Manuela Moriggi, Bartalucci Niccolò, Cristina Bucelli, Delfina Tosi, Umberto Gianelli, Alessandro Maria Maria Vannucchi, Alessandra Iurlo, Cecilia Gelfi, Alessandra Balduini, Alessandro Malara
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis. Leukemia 38 (9) (2024)
Paola Guglielmelli, Chiara Maccari, Benedetta Sordi, Manjola Balliu, Alessandro Atanasio, Carmela Mannarelli, Giulio Capecchi, Ilaria Sestini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Giada Rotunno, Eva Angori, Filippo C Borri, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood cancer journal 13 (1) (2023)
Paola Guglielmelli, Chiara Maccari, Benedetta Sordi, Manjola Balliu, Alessandro Atanasio, Carmela Mannarelli, Giulio Capecchi, Ilaria Sestini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Giada Rotunno, Eva Angori, Filippo C Borri, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood cancer journal 13 (1) (2023)
Tiziano Barbui, Alessandra Carobbio, Juergen Thiele, Naseema Gangat, Elisa Rumi, Alessandro Rambaldi, Alessandro Maria Maria Vannucchi, Ayalew Tefferi, null null
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients. Blood cancer journal 13 (1) (2023)
Laura Calabresi, Chiara Carretta, Simone Romagnoli, Giada Rotunno, Sandra Parenti, Matteo Bertesi, Bartalucci Niccolò, Sebastiano Rontauroli, Chiara Chiereghin, Sara Castellano, Giulia Gentili, Chiara Maccari, Fiorenza Vanderwert, Francesco Mannelli, Matteo Della Porta, Rossella Manfredini, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms. American journal of hematology (2023)
Tiziano Barbui, Alessandra Carobbio, Juergen Thiele, Naseema Gangat, Elisa Rumi, Alessandro Rambaldi, Alessandro Maria Maria Vannucchi, Ayalew Tefferi, null null
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients. Blood cancer journal 13 (1) (2023)
Omer S Karrar, Maymona Abdelmagid, Alessandro Maria Maria Vannucchi, Tiziano Barbui, Ayalew Tefferi, Naseema Gangat
ABO blood group type and risk of venous thrombosis in essential thrombocythemia. British journal of haematology (2023)
John O Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos, Francesco Passamonti, Raajit K Rampal, Adam J Mead, Gabriella Hobbs, Joseph M Scandura, Moshe Talpaz, Nikki Granacher, Tim C P Somervaille, Ronald Hoffman, Marielle J Wondergem, Mohamed E Salama, Gozde Colak, Jike Cui, Jean-Jacques Kiladjian, Alessandro Maria Maria Vannucchi, Srdan Verstovsek, Natalia Curto-García, Claire N Harrison, Vikas K Gupta
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Paola Guglielmelli, Chiara Maccari, Benedetta Sordi, Manjola Balliu, Alessandro Atanasio, Carmela Mannarelli, Giulio Capecchi, Ilaria Sestini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Giada Rotunno, Eva Angori, Filippo C Borri, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood cancer journal 13 (1) (2023)
John O Mascarenhas, Anna Rita Migliaccio, Heidi E Kosiorek, Rupali Bhave, Jeanne M Palmer, Andrew T Kuykendall, Ruben A Mesa, Raajit K Rampal, Aaron T Gerds, Abdulraheem Yacoub, Kristen Pettit, Moshe Talpaz, Rami S Komrokji, Marina Kremyanskaya, Agapito Gonzalez, Frank Fabris, Kathryn Johnson, Mikaela Dougherty, Erin M McGovern, Juan Esteban Arango Ossa, Dylan Domenico, Noushin Farnoud, Rona Singer Weinberg, Amy Kong, Vesna Najfeld, Alessandro Maria Maria Vannucchi, Francesca Arciprete, Maria Zingariello, Mario Falchi, Mohamed E Salama, Carolyn Mead-Harvey, Amylou C Dueck, Lilian Varricchio, Ronald Hoffman
A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tiziano Barbui, Alessandra Carobbio, Alessandro Maria Maria Vannucchi, Valerio De Stefano
Are the available data sufficient to suggest cytoreductive agents for patients with CHIP and stroke? Blood advances (2023)
Giuseppe Gaetano Loscocco, Stefano Ascani, Francesco Mannelli, Magda Zanelli, Giada Rotunno, Raffaella Santi, Alessandro Maria Maria Vannucchi
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement. American journal of hematology (2023)
Giuseppe Gaetano Loscocco, Giada Rotunno, Francesco Mannelli, Giacomo Coltro, Francesca Gesullo, Fabiana Pancani, Leonardo Signori, Chiara Maccari, Maria Esposito, Chiara Paoli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis. American journal of hematology (2023)
Ayalew Tefferi, Giuseppe Gaetano Loscocco, Faiqa Farrukh, Natasha Szuber, Francesco Mannelli, Animesh D Pardanani, Curtis A Hanson, Rhett P Ketterling, Valerio De Stefano, Alessandra Carobbio, Tiziano Barbui, Paola Guglielmelli, Naseema Gangat, Alessandro Maria Maria Vannucchi
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count. American journal of hematology (2023)
Tiziano Barbui, Alessandra Carobbio, Juergen Thiele, Naseema Gangat, Elisa Rumi, Alessandro Rambaldi, Alessandro Maria Maria Vannucchi, Ayalew Tefferi, null null
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients. Blood cancer journal 13 (1) (2023)
Paola Guglielmelli, Chiara Maccari, Benedetta Sordi, Manjola Balliu, Alessandro Atanasio, Carmela Mannarelli, Giulio Capecchi, Ilaria Sestini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Giada Rotunno, Eva Angori, Filippo C Borri, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood cancer journal 13 (1) (2023)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi
JAK2 inhibitor treatment of anemia in myelofibrosis. American journal of hematology (2023)
Giuseppe G Loscocco, Alessandro Maria Maria Vannucchi
Myeloid sarcoma: more and less than a distinct entity. Annals of hematology (2023)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi
JAK2 inhibitor treatment of anemia in myelofibrosis. American journal of hematology (2023)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi
JAK2 inhibitor treatment of anemia in myelofibrosis. American journal of hematology (2023)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi
JAK2 inhibitor treatment of anemia in myelofibrosis. American journal of hematology (2023)
Giuseppe Gaetano Loscocco, Raffaella Santi, Valentina Carrai, Giacomo Coltro, Francesco Mannelli, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis. International journal of laboratory hematology 44 (6) (2022)
Giuseppe G Loscocco, Alessandro Maria Maria Vannucchi
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives. International journal of hematology 115 (5) (2022)
Giacomo Coltro, Francesco Mannelli, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Giada Rotunno, Chiara Maccari, Fabiana Pancani, Alessandro Atanasio, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis. Blood cancer journal 12 (8) (2022)
Naseema Gangat, Natasha Szuber, Yamna Jadoon, Faiqa Farrukh, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Curtis A Hanson, Animesh D Pardanani, Valerio De Stefano, Tiziano Barbui, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events. Blood advances 6 (13) (2022)
Paola Guglielmelli, Giacomo Coltro, Francesco Mannelli, Giada Rotunno, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Chiara Maccari, Chiara Paoli, Simone Romagnoli, Bartalucci Niccolò, Alessandro Maria Maria Vannucchi
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera. Blood advances 6 (9) (2022)
Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo, Hans Michael Kvasnicka, Sa A Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E Bueso-Ramos, Jorge E Cortes, Paola Dal Cin, Courtney D D DiNardo, Hervé Dombret, Eric J Duncavage, Benjamin L Ebert, Elihu H Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S Hobbs, Ronald Hoffman, Elias J Jabbour, Jean-Jacques Kiladjian, Richard A Larson, Michelle M Le Beau, Mignon L-C Loh, Bob Löwenberg, Elizabeth A Macintyre, Luca Malcovati, Charles G Mullighan, Charlotte M Niemeyer, Olatoyosi M Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R Savona, Charles A Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A Stock, Richard M Stone, Martin S Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro Maria Maria Vannucchi, Paresh Vyas, Andrew H Wei, Olga K Weinberg, Agnieszka Świątek, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140 (11) (2022)
Claire N Harrison, Nicolaas Schaap, Alessandro Maria Maria Vannucchi, Jean-Jacques Kiladjian, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srdan Verstovsek, Shelonitda Rose, Jun Zhang, Oumar Sy, Ruben A Mesa
Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase-2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts. British journal of haematology 198 (2) (2022)
Elena Genovese, Margherita Mirabile, Sebastiano Rontauroli, Stefano Sartini, Sebastian Fantini, Lara Tavernari, Monica Maccaferri, Paola Guglielmelli, Elisa Bianchi, Sandra Parenti, Chiara Carretta, Selene Mallia, Sara Castellano, Corrado Colasante, Manjola Balliu, Niccolò Bartalucci, Raffaele Palmieri, Tiziana Ottone, Barbara Mora, Leonardo Potenza, Francesco Passamonti, Maria Teresa Teresa Voso, Mario Luppi, Alessandro Maria Maria Vannucchi, Enrico Tagliafico, Rossella Manfredini, null On Behalf Of The Mynerva MYeloid NEoplasms Research Venture Airc
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis. Antioxidants (Basel, Switzerland) 11 (1) (2022)
Tiziano Barbui, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Greta Carioli, Alessandro Rambaldi, Maria Chiara Finazzi, Marta Bellini, Elisa Rumi, Daniele Vanni, Oscar Borsani, Francesco Passamonti, Barbara Mora, Marco Brociner, Paola Guglielmelli, Chiara Paoli, Alberto Alvarez-Larran, Ana Triguero, Marta Garrote, Helna Pettersson, Björn Andréasson, Giovanni Barosi, Alessandro Maria Maria Vannucchi
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score. Blood cancer journal 12 (11) (2022)
Jürgen Thiele, Hans Michael Kvasnicka, Attilio Orazi, Umberto Gianelli, Naseema Gangat, Alessandro Maria Maria Vannucchi, Tiziano Barbui, Daniel A Arber, Ayalew Tefferi
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms. American journal of hematology (2022)
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, Courtney D D DiNardo, Lucy A Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro Maria Maria Vannucchi, Keyur Pravinchandra Patel, Daniel A Arber, Maria E Arcila, Rafael Bejar, Nancy Berliner, Michael J Borowitz, Susan Branford, Anna L Brown, Catherine A Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia-Manero, Torsten Haferlach, Eva Hellström-Lindberg, Annette S Kim, Jeffery M Klco, Rami S Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David Morrall Ross, Michael R Savona, Akiko Shimamura, Radek C Skoda, Francisco Solé, Richard M Stone, Ayalew Tefferi, Matthew J Walter, David Wu, Benjamin L Ebert, Mario Cazzola
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Blood 140 (21) (2022)
Francesco Mannelli, Sara Bencini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Benedetta Peruzzi, Giada Rotunno, Chiara Maccari, Francesca Gesullo, Miriam Borella, Chiara Paoli, Roberto Caporale, Carmela Mannarelli, Francesco Annunziato, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis. American journal of hematology 97 (7) (2022)
Natasha Szuber, Panagiota Toliopoulos, Lambert Busque, Sonia Cerquozzi, Lynda Foltz, Vikas Gupta, Ayalew Tefferi, Alessandro Maria Maria Vannucchi, Christopher Hillis, Brian Leber, Dawn Maze, Jaroslav Prchal, Harold J Olney, Shireen Sirhan
Perioperative management of myeloproliferative neoplasms: A pan-Canadian physician survey and international expert opinion. American journal of hematology 97 (12) (2022)
Francesco Mannelli, Francesca Gesullo, Carmela Mannarelli, Fiorenza Vanderwert, Stefano Lazzi, Francesco Mungai, Valentina Berti, Raffaella Santi, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Diagnostic and therapeutic challenges in mast cell sarcoma. American journal of hematology (2022)
John O Mascarenhas, Heidi E Kosiorek, Josef T Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire N Harrison, Mary Frances Frances McMullin, Alessandro Maria Maria Vannucchi, Joanne Ewing, Casey L O'Connell, Jean-Jacques Kiladjian, Adam J Mead, Elliott F Winton, David S Leibowitz, Valerio De Stefano, Murat O Arcasoy, Craig M Kessler, Rosalind Catchatourian, Damiano Rondelli, Richard T Silver, Andrea Bacigalupo, Arnon Nagler, Marina Kremyanskaya, Max Fine Levine, Juan Esteban Arango Ossa, Erin M McGovern, Lonette Sandy, Mohamad E Salama, Vesna Najfeld, Joseph Tripodi, Noushin Farnoud, Alexander V Penson, Rona Singer Weinberg, Leah Price, Judith D Goldberg, Tiziano Barbui, Roberto Marchioli, Gianni Tognoni, Raajit K Rampal, Ruben A Mesa, Amylou C Dueck, Ronald Hoffman
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia. Blood 139 (19) (2022)
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, Raajit K Rampal, Srdan Verstovsek, Moshe Talpaz, Jean-Jacques Kiladjian, Ruben A Mesa, Andrew T Kuykendall, Alessandro Maria Maria Vannucchi, Francesca Palandri, Sebastian Grosicki, Timothy Devos, Eric Jourdan, Marielle J Wondergem, Haifa Kathrin Al-Ali, Veronika Buxhofer-Ausch, Alberto Álvarez-Larrán, Andrea Patriarca, Marina Kremyanskaya, Adam J Mead, Sanjay Akhani, Yuri Sheikine, Gozde Colak, John O Mascarenhas
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. Future oncology (London, England) 18 (27) (2022)
Patrizia Zappasodi, Chiara Cattaneo, Virginia Valeria Ferretti, Roberto Mina, Andrés José María Ferreri, Francesco Merli, Margherita Oberti, Mauro Krampera, Alessandra Romano, Caterina Zerbi, Jacqueline Ferrari, Michele Cavo, Marco Salvini, Lorenza Bertù, Nicola Stefano Fracchiolla, Francesco Marchesi, Massimo Massaia, Vincenzo Marasco, Roberto Cairoli, Anna Maria Scattolin, Alessandro Maria Maria Vannucchi, Carlo Gambacorti-Passerini, Pellegrino Musto, Filippo Gherlinzoni, Antonio Cuneo, Antonello Pinto, Livio Trentin, Monica Bocchia, Sara Galimberti, Elisa Coviello, Maria Chiara Tisi, Alessandro Morotti, Brunangelo Falini, Mauro Turrini, Agostino Tafuri, Atto Billio, Massimo Gentile, Roberto Massimo Lemoli, Adriano Venditti, Matteo Giovanni Della Porta, Francesco Lanza, Luigi Rigacci, Patrizia Tosi, Sara Mohamed, Alessandro Corso, Mario Luppi, Nicola Giuliani, Alessandro Busca, Livio Pagano, Raffaele Bruno, Paolo Antonio Grossi, Paolo Corradini, Francesco Passamonti, Luca Arcaini, null null
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV. Hematological oncology (2022)
John O Mascarenhas, Francesco Passamonti, Kate Burbury, Tarec Christoffer El-Galaly, Aaron T Gerds, Vikas K Gupta, Brian Higgins, Kathrin Wonde, Candice Jamois, Bruno Kovic, Ling-Yuh Huw, Sudhakar Katakam, Margherita Maffioli, Ruben A Mesa, Jeanne Palmer, Marta Bellini, David Morrall Ross, Alessandro Maria Maria Vannucchi, Abdulraheem Yacoub
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study. Blood advances 6 (4) (2022)
Andreas Reiter, Juliana Schwaab, Daniel J DeAngelo, Jason Gotlib, Michael W Deininger, Kristen M Pettit, Iván Alvarez-Twose, Alessandro Maria Maria Vannucchi, Jens Peter Panse, Uwe Platzbecker, Olivier Hermine, Ingunn Dybedal, Hui-Min Lin, Svetlana N Rylova, Katrin Ehlert, Saša Dimitrijević, Deepti H Radia
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis. Blood advances 6 (21) (2022)
Srdan Verstovsek, Haifa Kathrin Al-Ali, John O Mascarenhas, Andrew Charles Perkins, Alessandro Maria Maria Vannucchi, Sanjay R Mohan, Bart L Scott, Dariusz Woszczyk, Steffen Koschmieder, Regina García-Delgado, Rejtő László, Jesse S McGreivy, Wayne P Rothbaum, Jean-Jacques Kiladjian
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis. Future oncology (London, England) (2022)
Giuseppe Gaetano Loscocco, Paola Guglielmelli, Francesco Mannelli, Barbara Mora, Carmela Mannarelli, Giada Rotunno, Fabiana Pancani, Chiara Maccari, Bartalucci Niccolò, Simone Romagnoli, Giacomo Coltro, Francesco Passamonti, Alessandro Maria Maria Vannucchi
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates. American journal of hematology 97 (9) (2022)
Naseema Gangat, Amritpal Singh, Natasha Szuber, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Curtis A Hanson, Animesh D Pardanani, Valerio De Stefano, Tiziano Barbui, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival. Journal of thrombosis and haemostasis : JTH 20 (10) (2022)
Tiziano Barbui, Valerio De Stefano, Alessandra Carobbio, Alessandra Iurlo, Alberto Alvarez-Larran, Beatriz Cuevas, Francisca Ferrer-Marín, Alessandro Maria Maria Vannucchi, Francesca Palandri, Claire Harrison, Hassan Sibai, Martin Griesshammer, Massimiliano Bonifacio, Elena M Elli, Chiara Trotti, Steffen Koschmieder, Giuseppe Carli, Giulia Benevolo, Jean-Christophe Ianotto, Swati Goel, Anna Falanga, Silvia Betti, Daniele Cattaneo, Eduardo Arellano-Rodrigo, Lara Mannelli, Nicola Vianelli, Andrew J Doyle, Vikas Gupta, Kai Wille, Douglas Tremblay, John O Mascarenhas
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients. Leukemia 35 (10) (2021)
Giuseppe Gaetano Loscocco, Paola Guglielmelli, Naseema Gangat, Elena Rossi, Carmela Mannarelli, Silvia Betti, Chiara Maccari, Francesco Ramundo, Yamna Jadoon, Francesca Gesullo, Sara Ceglie, Chiara Paoli, Animesh D Pardanani, Valerio De Stefano, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients. American journal of hematology 96 (11) (2021)
Ayalew Tefferi, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Polycythemia vera: historical oversights, diagnostic details, and therapeutic views. Leukemia 35 (12) (2021)
Ayalew Tefferi, Natasha Szuber, Animesh D Pardanani, Curtis A Hanson, Alessandro Maria Maria Vannucchi, Tiziano Barbui, Naseema Gangat
Extreme thrombocytosis in low-risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies. American journal of hematology 96 (6) (2021)
Srdan Verstovsek, Chih-Cheng Chen, Miklós Egyed, Martin Ellis, Maria Laura Fox, Yeow T Goh, Vikas K Gupta, Claire Harrison, Jean-Jacques Kiladjian, Mihaela C Lazaroiu, Adam J Mead, Donal McLornan, Mary Frances Frances McMullin, Stephen T Oh, Andrew Charles Perkins, Uwe Platzbecker, Christof Scheid, Alessandro Maria Maria Vannucchi, Sung-Soo Yoon, Mark M Kowalski, Ruben A Mesa
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic. Future oncology (London, England) 17 (12) (2021)
Paola Guglielmelli, Alessio Mazzoni, Laura Maggi, Seble Tekle Kiros, Lorenzo Zammarchi, Sofia Pilerci, Arianna Rocca, Michele Spinicci, Miriam Borella, Alessandro Bartoloni, Gian Maria Rossolini, Francesco Annunziato, Alessandro Maria Maria Vannucchi
Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib. American journal of hematology 96 (11) (2021)
Faiqa Farrukh, Paola Guglielmelli, Giuseppe Gaetano Loscocco, Animesh D Pardanani, Curtis A Hanson, Valerio De Stefano, Tiziano Barbui, Naseema Gangat, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia. American journal of hematology (2021)
Giuseppe Gaetano Loscocco, Elisabetta Antonioli, Ilaria Romano, Federica Vergoni, Giada Rotunno, Francesco Mannelli, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis. American journal of hematology 96 (6) (2021)
Paola Guglielmelli, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Elena Rossi, Francesco Mannelli, Francesco Ramundo, Giacomo Coltro, Silvia Betti, Chiara Maccari, Sara Ceglie, Patrizia Chiusolo, Chiara Paoli, Tiziano Barbui, Ayalew Tefferi, Valerio De Stefano, Alessandro Maria Maria Vannucchi
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis. Blood cancer journal 11 (12) (2021)
Paola Guglielmelli, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Chiara Maccari, Barbara Mora, Elisa Rumi, Ana Triguero, Maria Chiara Finazzi, Helna Pettersson, Chiara Paoli, Francesco Mannelli, Daniele Vanni, Alessandro Rambaldi, Francesco Passamonti, Alberto Alvarez-Larran, Bjorn I Andreasson, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of ERNEST Study. Blood advances (2021)
Naseema Gangat, Paola Guglielmelli, Natasha Szuber, Kebede H Begna, Mirinal S Patnaik, Mark R Litzow, Aref Al-Kali, James M Foran, Jeanne M Palmer, Hassan Alkhateeb, Michelle A Elliott, Curtis A Hanson, Animesh D Pardanani, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 96 (7) (2021)
Giuseppe Gaetano Loscocco, Giada Rotunno, Lara Mannelli, Francesco Mannelli, Federica Vergoni, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
BRAFV600E mutation in the wrong place: a case of concomitant polycythemia vera, hairy cell leukemia, and thyroid adenoma. Tumori 107 (6) (2021)
Alessandro Rambaldi, Alessandra Iurlo, Alessandro Maria Maria Vannucchi, Bruno Martino, Attilio Guarini, Marco Ruggeri, Nikolas von Bubnoff, Marianna De Muro, Mary Frances Frances McMullin, Stefania Luciani, Vincenzo Martinelli, Axel Nogai, Vittorio Rosti, Alessandra Ricco, Paolo Bettica, Sara Manzoni, Silvia Di Tollo
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program. Blood cancer journal 11 (3) (2021)
Giuseppe Gaetano Loscocco, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data. OncoTargets and therapy 13 (2020)
Giuseppe Gaetano Loscocco, Danilo Malandrino, Simone Barchiesi, Andrea Berni, Loredana Poggesi, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19. International journal of laboratory hematology 42 (6) (2020)
Giuseppe Gaetano Loscocco, Francesco Mannelli, Lara Mannelli, Federica Vergoni, Francesca Gesullo, Giada Rotunno, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease. American journal of hematology 95 (12) (2020)
Alessandro Maria Maria Vannucchi, Benedetta Sordi, Alessandro Morettini, Carlo Nozzoli, Loredana Poggesi, Filippo Pieralli, Alessandro Bartoloni, Alessandro Atanasio, Filippo Miselli, Chiara Paoli, Giuseppe Gaetano Loscocco, Andrea Fanelli, Ombretta Para, Andrea Berni, Irene Tassinari, Lorenzo Zammarchi, Laura Maggi, Alessio Mazzoni, Valentina Scotti, Giorgia Falchetti, Danilo Malandrino, Fabio Luise, Giovanni Millotti, Sara Bencini, Manuela Capone, Marie Pierre Piccinni, Francesco Annunziato, Paola Guglielmelli, null null
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia 35 (4) (2020)
Paola Guglielmelli, Alessandra Carobbio, Elisa Rumi, Valerio De Stefano, Lara Mannelli, Francesco Mannelli, Giada Rotunno, Giacomo Coltro, Silvia Betti, Chiara Cavalloni, Maria Chiara Finazzi, Juergen Thiele, Mario Cazzola, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis. Blood cancer journal 10 (2) (2020)
Massimo Breccia, Alfonso Piciocchi, Valerio De Stefano, Guido Finazzi, Alessandra Iurlo, Paola Fazi, Stefano Soddu, Bruno Martino, Francesca Palandri, Sergio Siragusa, Francesco Albano, Francesco Passamonti, Marco Vignetti, Alessandro Maria Maria Vannucchi
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey. Leukemia 34 (10) (2020)
Giuseppe Gaetano Loscocco, Francesco Mannelli, Paola Guglielmelli, Chiara Paoli, Ilaria Marone, Rosalba Cucci, Giacomo Coltro, Benedetta Sordi, Francesco Albano, Massimo Breccia, Valerio De Stefano, Guido Finazzi, Alessandra Iurlo, Bruno Martino, Francesca Palandri, Francesco Passamonti, Sergio Siragusa, Lara Mannelli, Duccio Fantoni, Paola Fazi, Sergio Amadori, Marco Vignetti, Tiziano Barbui, Alessandro Maria Maria Vannucchi
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative. American journal of hematology 94 (9) (2019)
Giada Rotunno, Carmela Mannarelli, Giada Brogi, Annalisa Pacilli, Francesca Gesullo, Francesco Mannelli, Sara Fiaccabrino, Benedetta Sordi, Chiara Paoli, Ilaria Marone, Elisa Rumi, Rossella Manfredini, Giovanni Barosi, Mario Cazzola, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation. Blood 133 (26) (2019)
Francesco Mannelli, Francesca Gesullo, Giada Rotunno, Annalisa Pacilli, Lisa Pieri, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Validation of the Mayo alliance prognostic system for mastocytosis. Blood cancer journal 9 (2) (2019)
Giacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, Christy M Finke, Prateek Pophali, Ryan Carr, Naseema Gangat, Moritz Binder, Animesh Pardanani, Martin Fernandez-Zapico, Keith D Robertson, Alberto Bosi, Nathalie Droin, Alessandro Maria Maria Vannucchi, Ayalew Tefferi, Anthony Hunter, Eric Padron, Eric Solary, Mirinal S Patnaik
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients. Leukemia 34 (5) (2019)
Paola Guglielmelli, Annalisa Pacilli, Giacomo Coltro, Francesco Mannelli, Lara Mannelli, Elisa Contini, Giada Rotunno, Bartalucci Niccolò, Sara Fiaccabrino, Benedetta Sordi, Giuseppe Gaetano Loscocco, Chiara Paoli, Alessandro Maria Maria Vannucchi
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms. American journal of hematology 95 (1) (2019)
Tiziano Barbui, Arianna Ghirardi, Arianna Masciulli, Alessandra Carobbio, Francesca Palandri, Nicola Vianelli, Valerio De Stefano, Silvia Betti, Ambra Di Veroli, Alessandra Iurlo, Daniele Cattaneo, Federica Delaini, Massimiliano Bonifacio, Luigi Scaffidi, Andrea Patriarca, Elisa Rumi, Ilaria Carola Casetti, Clemency Stephenson, Paola Guglielmelli, Elena Maria Elli, Miroslava Palova, Laura Bertolotti, Daniel Erez, Montse Gomez, Kai Wille, Manuel Perez-Encinas, Francesca Lunghi, Anna Angona, Maria Laura Fox, Eloise Beggiato, Giulia Benevolo, Giuseppe Carli, Rossella Cacciola, Mary Frances McMullin, Alessia Tieghi, Valle Recasens, Monia Marchetti, Martin Griesshammer, Alberto Alvarez-Larran, Alessandro Maria Maria Vannucchi, Guido Finazzi
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. Leukemia 33 (8) (2019)
Emanuela Sant'Antonio, Paola Guglielmelli, Lisa Pieri, Massimo Primignani, Maria Luigia Randi, Claudia Santarossa, Elisa Rumi, Francisco Cervantes, Federica Delaini, Alessandra Carobbio, Silvia Betti, Elena Rossi, Noa Lavi, Claire N Harrison, Natalia Curto-Garcia, Heinz Gisslinger, Bettina Gisslinger, Giorgina Specchia, Alessandra Ricco, Nicola Vianelli, Nicola Polverelli, Maya Koren-Michowitz, Marco Ruggeri, Francois Girodon, Martin Ellis, Alessandra Iurlo, Francesco Mannelli, Lara Mannelli, Benedetta Sordi, Giuseppe Gaetano Loscocco, Mario Cazzola, Valerio De Stefano, Tiziano Barbui, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases. American journal of hematology 95 (2) (2019)
Ayalew Tefferi, Sravanthi Lavu, Mythri Mudireddy, Terra L Lasho, Christy M Finke, Naseema Gangat, Animesh Pardanani, Curtis A Hanson, Carmela Mannarelli, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease. American journal of hematology 93 (4) (2019)

Alessandro Maria Maria Vannucchi.css-eqlu8i{font-size:small;padding-left:4px;} (Alessandro M Vannucchi, Alessandro Maria Vannucchi, Alessandro Maria Vannucchi, Alessandro Vannucchi)

Publication Activity (10 Years)

Top Topics

Top Venues

Alessandro Maria Maria Vannucchi (Alessandro M Vannucchi, Alessandro Maria Vannucchi, Alessandro Maria Vannucchi, Alessandro Vannucchi)